•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Vertex to Present at the Goldman Sachs Communacopia + Technology Conference
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
Vertex to Participate in Upcoming September Investor Conferences
Vertex Pharmaceuticals Up 15% in a Month: How to Play the Stock
Vertex Pharmaceuticals: A Biotech Cash Cow With Pipeline Upside?
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
Vertex Pharmaceuticals: I Was Wrong About Its Near-Term Prospects (Rating Upgrade)
Vertex Report: Rising Sales Tax Rates Signal a New Era of Tax Volatility
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?
3 Reasons Why Growth Investors Shouldn't Overlook Vertex (VERX)
Why Vertex Pharmaceuticals Stock Ticked Higher on Tuesday
Vertex Analysts Lower Their Forecasts Following Q2 Results
Vertex Expands Leadership Team to Power the Next Chapter of Growth
Vertex Pharmaceuticals: A Transition Year Into A Multi-Franchise Growth Story
Vertex, Inc. (VERX) Q2 2026 Earnings Call Transcript
Vertex Q2 Earnings Call Highlights
Vertex Pharmaceuticals Q2 Earnings Call Highlights
Compared to Estimates, Vertex (VERX) Q2 Earnings: A Look at Key Metrics
Vertex (VERX) Q2 Earnings and Revenues Top Estimates